Life Science Company News

Results 81 - 100 out of 500 displayed.

By: GlobeNewswire - 05 Jun 2023

Related companies: TG Therapeutics, Inc.

Walden Biosciences Announces First Subject Dosed in First-in-Humans Phase 1 Clinical Trial of WAL0921, in Development for Treatment of Chronic Kidney Diseases

By: GlobeNewswire - 05 Jun 2023

Related companies: Walden Biosciences | Walden Catalyst Management LLC

NovelMed Phase I Clinical Trial Shows Inhibition of the Alternative Pathway and Preservation of the Classical Pathway – A Long-Acting Anti-Properdin Monoclonal Antibody NM3086 for PNH Patients

By: GlobeNewswire - 05 Jun 2023

Updated RINGSIDE Phase 2 Results Featured in Poster Discussion Session at 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

By: GlobeNewswire - 05 Jun 2023

Related companies: Advaxis, Inc.

Revolo Biotherapeutics Presents New Data for ‘1805 in Inflammatory Bowel Disease and Rheumatoid Arthritis at the 5th Treg Directed Therapies Summit

By: GlobeNewswire - 05 Jun 2023

Related companies: Revolo Biotherapeutics

Leading Proxy Advisory Firms ISS and Glass Lewis Recommend Ardelyx Stockholders Vote in Favor of Proposed Share Increase

By: GlobeNewswire - 05 Jun 2023

Related companies: Ardelyx

Inspire Medical Systems, Inc. Announces Events at SLEEP 2023, the 37th Annual Meeting of the Associated Professional Sleep Societies

By: GlobeNewswire - 05 Jun 2023

Related companies: Inspire Medical Systems, Inc. | Insplorion AB

Taysha Gene Therapies Announces First Patient Dosed with TSHA-102 in the REVEAL Phase 1/2 Trial Under Investigation for the Treatment of Rett Syndrome

By: GlobeNewswire - 05 Jun 2023

Related companies: Taysha Gene Therapies

Candel Therapeutics to Participate in the 2023 Jefferies Healthcare Conference

By: GlobeNewswire - 05 Jun 2023

Related companies: Candel Therapeutics, Inc.

IN8bio Announces Positive INB-200 Phase 1 Data Update in Glioblastoma at the 2023 ASCO Annual Meeting

By: GlobeNewswire - 05 Jun 2023

Related companies: IN8bio Inc.

Carina Biotech Appoints Two New U.S. Based Biotechnology Executives to the Board of Directors

By: GlobeNewswire - 05 Jun 2023

Vor Bio to Participate in the Goldman Sachs Healthcare Conference

By: GlobeNewswire - 05 Jun 2023

Related companies: Vor BioPharma, Inc.

Timber Pharmaceuticals Announces FDA Grant of CARC Waiver for TMB-001

By: GlobeNewswire - 05 Jun 2023

Related companies: Timber Pharmaceuticals LLC

Enterin Announces the Start of a First-in-Human Study of ENT-03 in Obesity and Type 2 Diabetes

By: GlobeNewswire - 05 Jun 2023

Related companies: Enterin Inc.

NKGen Biotech Announces SNK01 Preclinical and Phase I/IIa Clinical Data Presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

By: GlobeNewswire - 05 Jun 2023

Related companies: NKGen Biotech, Inc.

Amolyt Pharma Announces Initiation of Phase 1 Clinical Trial of Peptide Growth Hormone Receptor Antagonist (GHRA), AZP-3813, for Acromegaly

By: GlobeNewswire - 05 Jun 2023

Related companies: Amolyt Pharma

Immuneering Completes Dose Escalation in the IMM-1-104 Phase 1 Clinical Trial for RAS-Mutant, Advanced Solid Tumors

By: GlobeNewswire - 05 Jun 2023

Related companies: Immuneering Corporation

Windtree Therapeutics to Host Virtual R&D and Investor Day Focusing on the Cardiogenic Shock Market, Istaroxime, Company Strategy and Planned Near-Term Milestones

By: GlobeNewswire - 05 Jun 2023

Related companies: Windtree Therapeutics, Inc.

Cue Biopharma to Present at the Jefferies 2023 Global Healthcare Conference

By: GlobeNewswire - 05 Jun 2023

Related companies: Cue Biopharma, Inc.

Replimune Appoints Veleka R. Peeples-Dyer to its Board of Directors

By: GlobeNewswire - 05 Jun 2023

Related companies: Replimune Group Inc.

Results 81 - 100 out of 500 displayed.

« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 »

Enhance your business development with Biotechgate

Try for free »